Review
Nature Reviews Cancer 7, 531-543 (July 2007) | doi:10.1038/nrc2170
Gene methylation and early detection of genitourinary cancer: the road ahead
Paul Cairns1 About the author
Abstract
DNA methylation is a common mechanism of inactivation of tumour-suppressor and other cancer genes in neoplastic cells. The advantages of gene methylation as a target for the detection and diagnosis of cancer in biopsy specimens and non-invasive body fluids such as urine or blood has led to many studies of application in genitourinary cancer. Here, we consider the background, promise and status, challenges and future directions of gene methylation and its clinical utility for the early detection of genitourinary cancer. The challenges of, and strategies for, advancing gene-methylation-based detection are relevant to all types of cancer.
- View At a Glance
Author affiliations
-
Departments of Surgical Oncology and Pathology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Email: Paul.Cairns@fccc.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic?ischemic ratsJournal of Cerebral Blood Flow & Metabolism Original Article
Spongistatin 1: a new chemosensitizing marine compound that degrades XIAPLeukemia Original Article
Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo ? use of the human tyrosinase promoter with human enhancersCancer Gene Therapy Original Article
Quantitative methylation analyses of resection margins predict local recurrences and disease-specific deaths in patients with head and neck squamous cell carcinomasBritish Journal of Cancer Original Article
See all 23 matches for Research